Teijin Limited
Climate Impact & Sustainability Data (2022)
Reporting Period: 2022
Environmental Metrics
ESG Focus Areas
- Regenerative Medicine
- Healthcare
- Innovation
- Collaboration
Social Achievements
- Establishment of a regenerative medicine platform to support the development and commercialization of innovative cancer treatments, addressing unmet medical needs.
Climate Goals & Targets
Medium-term Goals:
- Support about 10 projects annually
Short-term Goals:
- Open a CDMO facility in January 2024
Environmental Challenges
- Many academic institutions and start-up companies are unable to commercialize their regenerative medicine research and development independently due to lack of specialized knowledge, practical experience, and commercialization know-how.
Mitigation Strategies
- Establishment of a regenerative medicine platform providing academic institutions with professional expertise and commercialization know-how on a collaborative basis.